Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 February 2026

12 new medicines recommended for approval EMA’s human medicines committee (CHMP) recommended 12 medicines for approval at its February 2026 meeting. The committee recommended granting a marketing authorisation for mCombriax (influenza and COVID-19 mR... [6115 chars]